PU.1: A crucial and versatile player in hematopoiesis and leukemia

被引:70
|
作者
Kastner, Philippe
Chan, Susan
机构
[1] IGBMC, F-67404 Illkirch Graffenstaden, France
[2] INSERM, F-67400 Illkirch Graffenstaden, France
[3] CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France
[4] Univ Strasbourg 1, F-67000 Strasbourg, France
关键词
Spi-1; hematopoiesis; leukemia;
D O I
10.1016/j.biocel.2007.01.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purine Rich Box-1 (PU.1)/SFFV Proviral Integration Site-1 (Spi-1) is an Ets-family transcription factor, which was first characterized as an oncogene in Friend's murine erythroleukemia, and subsequently, as a transcriptional regulator of myeloid promoters. PU.1 has since emerged as a central regulator of all hematopoietic cell lineages. PU.1 is essential for terminal myeloid cell differentiation, B and T cell development, erythropoiesis and hematopoietic stem cell maintenance. These pleiotropic functions are reflected by its complex and dynamic expression pattern during hematopoiesis. Factors regulating this complex expression are only beginning to be revealed. Interestingly, recent work has provided strong evidence that suppression of PU.1 function is critical for the leukemic transformation of myeloid cells, both in mouse and man. Thus PU.1 is a multi-faceted protein that controls numerous normal and pathogenic functions within the hematopoietic system. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:22 / 27
页数:6
相关论文
共 50 条
  • [41] PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis
    Huang, Gang
    Zhang, Pu
    Hirai, Hideyo
    Elf, Shannon
    Yan, Xiaomei
    Chen, Zhao
    Koschmieder, Steffen
    Okuno, Yutaka
    Dayaram, Tajhal
    Growney, Joseph D.
    Shivdasani, Ramesh A.
    Gilliland, D. Gary
    Speck, Nancy A.
    Nimer, Stephen D.
    Tenen, Daniel G.
    NATURE GENETICS, 2008, 40 (01) : 51 - 60
  • [42] PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis
    Gang Huang
    Pu Zhang
    Hideyo Hirai
    Shannon Elf
    Xiaomei Yan
    Zhao Chen
    Steffen Koschmieder
    Yutaka Okuno
    Tajhal Dayaram
    Joseph D Growney
    Ramesh A Shivdasani
    D Gary Gilliland
    Nancy A Speck
    Stephen D Nimer
    Daniel G Tenen
    Nature Genetics, 2008, 40 : 51 - 60
  • [43] Is PU.1 pivotal to APL?
    Cook, W
    BLOOD, 2006, 107 (08) : 3017 - 3018
  • [44] PU.1 expression in microglia
    Walton, MR
    Gibbons, H
    MacGibbon, GA
    Sirimanne, E
    Saura, J
    Gluckman, PD
    Dragunow, M
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 104 (02) : 109 - 115
  • [45] PU.1 pinned down
    Buckland, J
    NATURE REVIEWS IMMUNOLOGY, 2002, 2 (03) : 149 - 149
  • [46] PU.1 pinned down
    Jenny Buckland
    Nature Reviews Immunology, 2002, 2 : 149 - 149
  • [47] Essential Role for PU.1 in MEIS1 Activation and MLL Fusion Leukemia
    Zhou, Jing
    Li, Bo
    Wu, Jun
    He, Fuhong
    Li, Qiang
    Yan, Xiaomei
    Zhang, Yue
    Zhang, Lixia
    Zhao, Xinghui
    Yan, Jin
    Nobrega, Marcelo
    Tenen, Daniel G.
    Huang, Gang
    Wang, Qian-fei
    BLOOD, 2011, 118 (21) : 1480 - 1481
  • [48] Transcriptional regulation of the stem cell leukemia gene by PU.1 and Elf-1
    Bockamp, EO
    Fordham, JL
    Göttgens, B
    Murrell, AM
    Sanchez, MJ
    Green, AR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) : 29032 - 29042
  • [49] Development of macrophages from PU.1(-/-) ES cells is restored by a PU.1 minigene.
    Olson, MC
    Scott, EW
    Fisher, R
    Singh, H
    Simon, MC
    BLOOD, 1996, 88 (10) : 185 - 185
  • [50] Overcoming the PU.1 defect:: Regulation of PU.1 in vivo through use of tamoxifen.
    O'Malley, KA
    Brown, GAJ
    Weil, D
    Venteicher, A
    Gadue, P
    Scott, EW
    BLOOD, 2002, 100 (11) : 298A - 298A